Evidence map›Paper›PMID 39027299›Full record

ArticleChemical science2024

Dual-modal imaging-guided agent based on NIR-II aggregation-induced emission luminogens with balanced phototheranostic performance.

Chengjun Dong, Ziwen Zhang, Hongyu Wu, Xinting Liang, Shihao Pang, Kehuan Wu, Jie Sun, Xuemei Dong, Lixin Sun, Xianfeng Gu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chengjun DongKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.ORCID https://orcid.org/0000-0002-3597-6818
Ziwen ZhangDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University Shanghai 201203 P. R. China.
Hongyu WuDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University Shanghai 201203 P. R. China.
Xinting LiangKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.
Shihao PangKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.
Kehuan WuDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University Shanghai 201203 P. R. China.
Jie SunKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.
Xuemei DongKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.ORCID https://orcid.org/0009-0002-2329-1704
Lixin SunKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.ORCID https://orcid.org/0000-0002-8837-8766
Xianfeng GuDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University Shanghai 201203 P. R. China.ORCID https://orcid.org/0000-0002-7462-7266
Chunchang ZhaoKey Laboratory for Advanced Materials and Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology Shanghai 200237 P. R. China zhaocchang@ecust.edu.cn.ORCID https://orcid.org/0000-0003-2952-7036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phototherapy has garnered considerable interest for its potential to revolutionize conventional cancer treatment. Organic materials with near-infrared II (NIR-II, 1000-1700 nm) fluorescence and photothermal effects are key for precise tumor diagnosis and treatment, yet optimizing their output for higher resolution and reduced photodamage remains a challenge. Herein, a multifunctional NIR-II photosensitizer (LSC) has been developed using the aggregation-induced emission (AIE) technology. The utilization of thieno[3,2-

Identifiers

PMID39027299
PMCPMC11253120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.